ArticleFrontiers in surgery2026
Technical progress and clinical application of distal nerve transfers.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Distal nerve transfer surgery has emerged as a transformative strategy in the treatment of peripheral nerve injuries. However, substantial heterogeneity in injury patterns, donor selection, surgical techniques, and outcome measures has produced conflicting evidence and limited consensus regarding optimal reconstructive approaches. To address these limitations, we propose a concept of four-level decision-making framework integrated with a donor feasibility triad consisting of availability, suitability, and acceptability. Methods: This paper integrates the author's surgical experience with current literature and conceptualizes the decision-making process through the proposed framework. No formal systematic review or original data collection was performed. Three testable predictions were derived and assessed using evidence from systematic reviews, meta-analyses, and large clinical series. Results: The reviewed literature demonstrated substantial heterogeneity and frequent contradictions regarding donor selection, reconstructive strategies, and technical approaches. There was also substantial heterogeneity in the evaluation of the three predictions, as they were primarily qualitative constructs without standardized quantitative thresholds or uniform assessment criteria. Prediction 1, proposing a worse outcome prognosis with an increase in lesion severity, was consistently supported. Prediction 2, proposing superior outcomes with feasibility triad-compliant donor selection, remains insufficiently evaluated. Prediction 3, proposing that technical modifications and adjunctive modalities cannot fully compensate for poor donor feasibility, was supported. Discussion: The framework does not prescribe a fixed algorithm but provides a structured language to articulate why a donor choice was made, what constraints existed, and where uncertainties lie, enabling meaningful comparison across heterogeneous clinical scenarios. Prospective validation of the predictions and standardized outcome reporting are needed to improve interpretability and reproducibility across studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.